MY157743A - Emulsion-type liquid composition for oral cavity and process for production thereof - Google Patents
Emulsion-type liquid composition for oral cavity and process for production thereofInfo
- Publication number
- MY157743A MY157743A MYPI2012001873A MYPI2012001873A MY157743A MY 157743 A MY157743 A MY 157743A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY PI2012001873 A MYPI2012001873 A MY PI2012001873A MY 157743 A MY157743 A MY 157743A
- Authority
- MY
- Malaysia
- Prior art keywords
- emulsion
- oral cavity
- type liquid
- liquid composition
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000007788 liquid Substances 0.000 title abstract 4
- 210000000214 mouth Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 235000011187 glycerol Nutrition 0.000 abstract 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 abstract 2
- -1 POLYOXYETHYLENE Polymers 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000000622 irritating effect Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
DISCLOSED HEREIN IS AN EMULSION-TYPE LIQUID COMPOSITION FOR THE ORAL CAVITY, WHICH COMPRISES A LIQUID ORAL COMPOSITION SUBSTANTIALLY FREE OF ETHANOL THAT CONTAINS (A) ISOPROPYL METHYL PHENOL, (B) POLYOXYETHYLENE HYDROGENATED CASTOR OIL HAVING AN E.O. OF 40 TO 100 MOL, (C) (C-1) A DECAGLYCERIN MONOFATTY ACID ESTER AND (C-2) A TRIFATTY ACID GLYCERYL, AND (D) A POLYHYDRIC ALCOHOL SELECTED FROM GLYCERIN, PROPYLENE GLYCOL HAVING AN AVERAGE MOLECULAR WEIGHT OF 190 TO 630, WHEREIN THE [(B)+(C-1)]/[(C-2)] RATIO IS 0.77 TO 1.87 BY WEIGHT, THE COMPONENT (D) IS CONTAINED IN AN MOUNT OF 5 TO 15 WT%, AND GLYCERIN IS CONTAINED IN AN AMOUNT OF 0.003 WT% OR MORE. THE EMULSION TYPE LIQUID COMPOSITION HAS A HIGH INFILTRATION/STERILIZATION EFFECT ON A PERIODONTOPATHIC BIOFILM, ENABLES HIGH ACCUMULATION OF ISOPROPYL METHYL PHENOL IN THE ORAL CAVITY, AND HAS GOOD APPEARANCE STABILITY AND MILD IRRITATING PROPERTIES. ALSO DISCLOSED IS A PROCESS FOR PRODUCING THE COMPOSITION, WHICH INCLUDES MIXING THE COMPONENTS, (A), (B) AND (D) WITH ONE ANOTHER AND ADDING THE COMPONENT (C) IN THE FORM OF AN EMULSION TO THE RESULTING MIXTURE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009290242 | 2009-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY157743A true MY157743A (en) | 2016-07-15 |
Family
ID=44195392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012001873A MY157743A (en) | 2009-12-22 | 2010-11-11 | Emulsion-type liquid composition for oral cavity and process for production thereof |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5690744B2 (en) |
| KR (1) | KR101780837B1 (en) |
| CN (1) | CN102655844B (en) |
| MY (1) | MY157743A (en) |
| WO (1) | WO2011077847A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5953608B2 (en) * | 2012-05-25 | 2016-07-20 | 日本ゼトック株式会社 | Biofilm inhibitor |
| JP6331641B2 (en) * | 2014-04-21 | 2018-05-30 | ライオン株式会社 | Liquid oral composition, method for producing the same, and method for stabilizing low temperature of allantoin or a derivative thereof in the composition |
| CN106456485B (en) * | 2014-04-21 | 2019-08-09 | 狮王株式会社 | Liquid oral composition and method for improving freeze recovery thereof |
| JP6634284B2 (en) * | 2015-12-25 | 2020-01-22 | 日油株式会社 | Concentrated antimicrobial composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005179231A (en) * | 2003-12-18 | 2005-07-07 | Lion Corp | Liquid oral composition |
| JP4873154B2 (en) * | 2004-12-24 | 2012-02-08 | ライオン株式会社 | Liquid oral composition |
| JP2006182662A (en) * | 2004-12-27 | 2006-07-13 | Lion Corp | Dentifrice composition |
| WO2007148551A1 (en) * | 2006-06-23 | 2007-12-27 | Lion Corporation | Liquid oral composition containing isopropylmethylphenol |
-
2010
- 2010-11-11 MY MYPI2012001873A patent/MY157743A/en unknown
- 2010-11-11 KR KR1020127018088A patent/KR101780837B1/en not_active Expired - Fee Related
- 2010-11-11 CN CN201080056981.1A patent/CN102655844B/en not_active Expired - Fee Related
- 2010-11-11 WO PCT/JP2010/070070 patent/WO2011077847A1/en not_active Ceased
- 2010-11-11 JP JP2011547396A patent/JP5690744B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2011077847A1 (en) | 2013-05-02 |
| CN102655844B (en) | 2014-07-09 |
| CN102655844A (en) | 2012-09-05 |
| JP5690744B2 (en) | 2015-03-25 |
| WO2011077847A1 (en) | 2011-06-30 |
| KR20120112538A (en) | 2012-10-11 |
| KR101780837B1 (en) | 2017-09-21 |
| HK1173960A1 (en) | 2013-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA94052C2 (en) | Pyridazine derivatives | |
| TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
| WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
| WO2010034917A3 (en) | Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent | |
| MX377553B (en) | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USE THEREOF. | |
| WO2008030744A3 (en) | Inhibitors of c-met and uses thereof | |
| CA2757418C (en) | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same | |
| WO2009100441A3 (en) | Depot formulations | |
| WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
| EA201071167A1 (en) | STABILIZED OLEOSOMIC COMPOSITIONS AND METHODS FOR THEIR PRODUCTION | |
| WO2006113631A3 (en) | Bioenhanced compositions | |
| MY157740A (en) | Liquid oral composition and method for producing same | |
| CY1116490T1 (en) | KLEVIDIPIN PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING CONCENTRATING LOW PRIMARY CONCENTRATIONS | |
| MY157743A (en) | Emulsion-type liquid composition for oral cavity and process for production thereof | |
| WO2013117770A3 (en) | Cosmetic treatment method, and composition comprising a glyoxylic acid ester | |
| MX2012007246A (en) | Emulsion composition. | |
| CA2798180A1 (en) | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same | |
| SI2021002T1 (en) | Pharmaceutical composition comprising olmesartan medoxomil | |
| MX2009003169A (en) | Sulfonamide derivatives. | |
| PE20011223A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING PEMETREXED AND AN ANTIOXIDANT SUCH AS MONOTHIOGLYCEROL, L-CYSTEINE AND THIOGLICOLIC ACID | |
| MY139522A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
| MY164603A (en) | Liquid composition for oral cavity and method for stable addition of components to composition | |
| MY147188A (en) | Substituted imidazole compounds as ksp inhibitors | |
| PL1718679T3 (en) | Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same | |
| WO2009083664A8 (en) | Novel taxoid-based compositions |